The firm is investing in an additional site located adjacent to its existing facility to help its pharmaceutical clients accelerate new drug products from discovery to production.
As part of the expansion, Onyx has already recruited several extra chemists to support its clients requirements as it continues to invest in its Wearside operations.
Denise Bowser, commercial director at Onyx Scientific, said: “It’s been a challenging few years for contract service firms across the industry but our team here in Sunderland has continued to work hard to always exceed clients’ expectations, which has led to a very loyal customer base and regular repeat business.
“Although we have come to the end of a very positive year, we have never been a firm to rest of our laurels.
“With the support of our parent company Ipca Laboratories in India, we are very much investing in our physical capacity, equipment and technical resource.
“We remain committed to supporting drug developers across the globe with routine chemistry and overcoming early stage complex chemistry challenges to allow them to progress, scale-up and meet clinical deadline with robust lead candidates.”